• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.单克隆抗体与人Fc受体样2的结合可下调B细胞受体介导的信号传导。
Immunology. 2014 Nov;143(3):341-53. doi: 10.1111/imm.12311.
2
Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.Fc受体样5通过募集SHP-1酪氨酸磷酸酶抑制B细胞活化。
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9770-5. doi: 10.1073/pnas.0703354104. Epub 2007 May 23.
3
FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells.FcR 样 2 抑制 B 细胞受体介导的 B 细胞活化。
J Immunol. 2010 Dec 15;185(12):7405-12. doi: 10.4049/jimmunol.1002305. Epub 2010 Nov 10.
4
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.FCRL2表达可预测慢性淋巴细胞白血病的IGHV突变状态及临床进展。
Blood. 2008 Jul 1;112(1):179-87. doi: 10.1182/blood-2008-01-131359. Epub 2008 Feb 26.
5
Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.抗原刺激B淋巴细胞激活的CD22中含Src同源2结构域蛋白酪氨酸磷酸酶-1的新型结合位点。
J Biol Chem. 2008 Jan 18;283(3):1653-1659. doi: 10.1074/jbc.M706584200. Epub 2007 Nov 15.
6
Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling.CD20诱导的胞质钙通量依赖于B细胞抗原受体信号传导。
J Biol Chem. 2008 Jun 20;283(25):16971-84. doi: 10.1074/jbc.M708459200. Epub 2008 Apr 21.
7
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.通过Fc工程抗体共同结合CD19和FcγRIIb抑制原发性人B细胞的B细胞受体介导的活化。
Mol Immunol. 2008 Sep;45(15):3926-33. doi: 10.1016/j.molimm.2008.06.027. Epub 2008 Aug 8.
8
CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation.CD22连接可抑制激活时下游B细胞受体信号传导和Ca(2+)通量。
Arthritis Rheum. 2013 Mar;65(3):770-9. doi: 10.1002/art.37818.
9
Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells.除了依赖ITIM/SHP-1的途径外,CD22在B细胞中通过一种不依赖ITIM/SHP-1的途径,与Grb2和质膜钙ATP酶协同作用,减弱Ca2+内流信号。
Oncotarget. 2016 Aug 30;7(35):56129-56146. doi: 10.18632/oncotarget.9794.
10
CD72 negatively regulates signaling through the antigen receptor of B cells.CD72通过B细胞抗原受体对信号传导起负调节作用。
J Immunol. 2000 Feb 1;164(3):1223-9. doi: 10.4049/jimmunol.164.3.1223.

引用本文的文献

1
FcRL1, a New B-Cell-Activating Co-Receptor.FcRL1,一种新型B细胞激活共受体。
Int J Mol Sci. 2025 Jun 30;26(13):6306. doi: 10.3390/ijms26136306.
2
FCRL1 Regulates B Cell Receptor-Induced ERK Activation through GRB2.FCRL1 通过 GRB2 调节 B 细胞受体诱导的 ERK 激活。
J Immunol. 2021 Dec 1;207(11):2688-2698. doi: 10.4049/jimmunol.2100218. Epub 2021 Oct 25.
3
Expression profiling of genes in rheumatoid fibroblast-like synoviocytes regulated by tumor necrosis factor-like ligand 1A using cDNA microarray analysis.利用cDNA微阵列分析对肿瘤坏死因子样配体1A调控的类风湿性成纤维细胞样滑膜细胞中的基因进行表达谱分析。
Biomed Rep. 2019 Jul;1(1):1-5. doi: 10.3892/br.2019.1216. Epub 2019 May 22.
4
1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.1q23.1 杂合缺失和 Fc 受体样家族基因下调导致慢性淋巴细胞白血病预后不良。
Clin Exp Med. 2019 May;19(2):261-267. doi: 10.1007/s10238-019-00551-0. Epub 2019 Mar 15.
5
Targeted Therapies in Adult B-Cell Malignancies.成人B细胞恶性肿瘤的靶向治疗
Biomed Res Int. 2015;2015:217593. doi: 10.1155/2015/217593. Epub 2015 Sep 6.

本文引用的文献

1
Expression, Purification and Characterization of Three Overlapping Immunodominant Recombinant Fragments from Bordetella pertussis Filamentous Hemagglutinin.百日咳博德特氏菌丝状血凝素三个重叠免疫显性重组片段的表达、纯化及特性分析
Avicenna J Med Biotechnol. 2013 Jan;5(1):20-8.
2
Optimization of Gene Transfection in Murine Myeloma Cell Lines using Different Transfection Reagents.使用不同转染试剂对小鼠骨髓瘤细胞系基因转染进行优化
Avicenna J Med Biotechnol. 2010 Jul;2(3):123-30.
3
FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling.FcRL4 作为一种适应性先天分子开关,可抑制 BCR 信号转导并增强 TLR 信号转导。
Blood. 2011 Dec 8;118(24):6332-41. doi: 10.1182/blood-2011-05-353102. Epub 2011 Sep 8.
4
Characterization of novel murine monoclonal antibodies directed against the extracellular domain of human HER2 tyrosine kinase receptor.针对人HER2酪氨酸激酶受体细胞外结构域的新型鼠源单克隆抗体的特性分析
Hybridoma (Larchmt). 2011 Aug;30(4):347-53. doi: 10.1089/hyb.2011.0023.
5
Regulation of BCR signaling.BCR 信号转导的调控。
Mol Immunol. 2011 Jun;48(11):1287-91. doi: 10.1016/j.molimm.2010.12.007. Epub 2010 Dec 31.
6
FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells.FcR 样 2 抑制 B 细胞受体介导的 B 细胞活化。
J Immunol. 2010 Dec 15;185(12):7405-12. doi: 10.4049/jimmunol.1002305. Epub 2010 Nov 10.
7
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy.类风湿关节炎患者的 B 细胞表达 CD86 和 FcγRIIb 发生重要改变,抗肿瘤坏死因子治疗可调节这些改变。
Arthritis Res Ther. 2010;12(2):R68. doi: 10.1186/ar2985. Epub 2010 Apr 15.
8
FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.FCRL3是一种自身免疫易感性基因,对B细胞受体介导的信号传导具有抑制作用。
J Immunol. 2009 Nov 1;183(9):5502-10. doi: 10.4049/jimmunol.0901982.
9
Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.Fc 受体样 1-5 分子在 B 细胞慢性淋巴细胞白血病的进展型和惰性临床亚型中表达相似。
Int J Cancer. 2008 Nov 1;123(9):2113-9. doi: 10.1002/ijc.23751.
10
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.FCRL2表达可预测慢性淋巴细胞白血病的IGHV突变状态及临床进展。
Blood. 2008 Jul 1;112(1):179-87. doi: 10.1182/blood-2008-01-131359. Epub 2008 Feb 26.

单克隆抗体与人Fc受体样2的结合可下调B细胞受体介导的信号传导。

Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

作者信息

Shabani Mahdi, Bayat Ali Ahmad, Jeddi-Tehrani Mahmood, Rabbani Hodjatallah, Hojjat-Farsangi Mohammad, Ulivieri Cristina, Amirghofran Zahra, Baldari Cosima Tatiana, Shokri Fazel

机构信息

Monoclonal Antibody Research Centre, Avicenna Research Institute, ACECR, Tehran, Iran; Department of Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Immunology. 2014 Nov;143(3):341-53. doi: 10.1111/imm.12311.

DOI:10.1111/imm.12311
PMID:24797767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4212948/
Abstract

B-cell antigen receptor (BCR) signalling and its regulation through negative and positive regulators are critical for balancing B-cell response and function. Human Fc receptor like-2 (FCRL2), a member of the newly identified FCRL family, could influence B-cell signalling due to possession of both immunoreceptor tyrosine-based activation and inhibitory motifs (ITAM and ITIM). Since the natural ligand of FCRL2 has not been identified, we generated FCRL2-specific monoclonal antibodies (mAbs) and employed them to investigate the influence of FCRL2 stimulation on BCR signalling in an FCRL2-expressing B-cell line. Two anti-FCRL2 mAb-producing hybridoma clones (5A7-E7 and 3D8-G8) were selected. None of the mAbs displayed any cross-reactivity with the other members of the FCRL family including recombinant FCRL1, -3, -4 and -5, as tested by FACS and ELISA techniques. Engagement of the FCRL2 by these mAbs resulted in significant inhibition of BCR signalling mediators such as calcium mobilization and phosphorylation of the mitogen-activated protein kinases Erk, p38 and Jnk. These findings indicate that the FCRL2 ITIM motifs are functional and the anti-FCRL2 mAbs may mimic the natural ligand of FCRL2 by induction of inhibitory signals in B cells.

摘要

B细胞抗原受体(BCR)信号传导及其通过正负调节因子的调控对于平衡B细胞反应和功能至关重要。人Fc受体样2(FCRL2)是新发现的FCRL家族成员之一,因其同时拥有基于免疫受体酪氨酸的激活基序和抑制基序(ITAM和ITIM),可能影响B细胞信号传导。由于FCRL2的天然配体尚未确定,我们制备了FCRL2特异性单克隆抗体(mAb),并利用它们研究FCRL2刺激对表达FCRL2的B细胞系中BCR信号传导的影响。选择了两个产生抗FCRL2 mAb的杂交瘤克隆(5A7-E7和3D8-G8)。通过FACS和ELISA技术检测,这些mAb与FCRL家族的其他成员(包括重组FCRL1、-3、-4和-5)均无交叉反应。这些mAb与FCRL2结合导致BCR信号传导介质的显著抑制,如钙动员以及丝裂原活化蛋白激酶Erk、p38和Jnk的磷酸化。这些发现表明FCRL2的ITIM基序具有功能,抗FCRL2 mAb可能通过在B细胞中诱导抑制信号来模拟FCRL2的天然配体。